EZETIMIB ROSUVAST Viatris cpr pell 10/20mg 30 pce

7680672760070 CH-67276 C10BA06 07.12.0.

Reimbursement limitations:

EZET_ROS_VIA

EZETIMIB-ROSUVASTATIN VIATRIS est indiqué comme traitement substitutif chez le patient adulte qui reçoit déjà de …

EZETIMIB ROSUVAST Viatris cpr pell 10/20mg 30 pce
EZETIMIB ROSUVAST Viatris cpr pell 10/20mg 30 pce
EZETIMIB ROSUVAST Viatris cpr pell 10/20mg 30 pce
1 / 3
google

Details

Product number
6727602
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
Filmtablette: rosuvastatinum 20 mg ut rosuvastatinum calcicum, ezetimibum 10.00 mg, amylum pregelificatum, cellulosum microcristallinum, megluminum, calcii hydrogenophosphas dihydricus, crospovidonum, silica colloidalis anhydrica, natrii stearylis fumaras, mannitolum, E 320, natrii laurilsulfas, carmellosum natricum conexum, povidonum K 30, E 172 (rubrum), magnesii stearas, Überzug: hypromellosum, titanii dioxidum, macrogolum, E 172 (rubrum), pro compresso obducto corresp. natrium 3.09 mg.

Articles (1)

Ezetimib-Rosuvastatin Viatris 10 mg / 20 mg, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
08/02/2025
Patient information leaflet
Français
08/02/2025
Patient information leaflet
Italien
08/02/2025
Professional SmPC
Allemand
08/02/2025
Professional SmPC
Français
08/02/2025
Professional SmPC
Italien
08/02/2025

Detailed composition

Substance Quantity Type Category
FTAB
20.0 MG Substance Wirkstoff (Principe actif)
FTAB
- Substance WIZUS
FTAB
10.0 MG Substance Wirkstoff (Principe actif)
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance ANTOX
FTAB
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance FTODK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance HNIDK
FTAB
- Substance FTODK
FTAB
3.09 MG Substance HBESI

Reimbursement information

Public price
CHF 43.55
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/10/2021

Authorization holder

Viatris Pharma GmbH

6312 Steinhausen

Authorization information

Swissmedic authorization number
67276
Drug name
Ezetimib-Rosuvastatin Viatris, Filmtabletten
Galenic form
FILM
ATC Code
C10BA06
Authorization status
Z
Dispensation category
B
First authorization
13/07/2021
Authorization expiration date
31/12/9999
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration

Packaging details

Description (FR)
EZETIMIB ROSUVAST Viatris cpr pell 10/20mg 30 pce
Description (DE)
EZETIMIB ROSUVAST Viatris Filmtabl 10/20mg 30 Stk
Market launch
13/07/2021
Narcotic (BTM)
No

Other packaging sizes

EZETIMIB ROSUVAST Viatris cpr pell 10/10mg 30 pce
30 TABL
View
EZETIMIB ROSUVAST Viatris cpr pell 10/10mg 90 pce
90 TABL
View
EZETIMIB ROSUVAST Viatris cpr pell 10/20mg 90 pce
90 TABL
View